Navigation Links
ACTEMRA (R) (tocilizumab) Significantly Reduced Signs and Symptoms of Rheumatoid Arthritis in Patients Who Failed Prior Treatments
Date:10/25/2008

- Results of two Phase III studies affirmed the clinical benefits of ACTEMRA -

NUTLEY, N.J., Oct. 25 /PRNewswire/ -- Data from two Phase III studies showed that patients who suffer from the debilitating and painful effects of rheumatoid arthritis (RA) achieved significant improvements in signs and symptoms when treated with ACTEMRA(R) (tocilizumab) alone or in combination with methotrexate compared with methotrexate alone. The final results of both studies will be presented as oral presentations, along with 13 other abstracts which evaluate ACTEMRA in patients with moderately to severely active RA, at the American College of Rheumatology (ACR) Annual Scientific Meeting in San Francisco, October 24-29.

Results of the RADIATE study, which evaluated difficult-to-treat patients who failed to respond to prior anti-tumor necrosis factor (TNF)-alpha therapies, demonstrated that half of patients treated with ACTEMRA (8 mg/kg) in combination with methotrexate achieved a 20 percent reduction (ACR20)(1) in RA signs and symptoms, compared with 10 percent of patients treated with methotrexate alone.

"Despite treatment with existing therapies, many patients with RA continue to experience symptoms of joint pain and stiffness," said Mark Genovese, M.D., Professor of Medicine at Stanford University School of Medicine. "The compelling results of these studies further support the efficacy and safety of ACTEMRA as a potential new treatment option for managing the chronic signs and symptoms of this debilitating disease."

The AMBITION study, which examined the effects of ACTEMRA (8 mg/kg) as monotherapy, showed that 70 percent of patients receiving ACTEMRA achieved a 20 percent improvement in their signs and symptoms (ACR20), compared with 53 percent of patients receiving methotrexate alone. The study not only successfully met its primary endpoint of non-inferiority in patients with moderate to severe RA, but also demonstrated superiority over the stand
'/>"/>

SOURCE Hoffmann-La Roche Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. ACTEMRA(R) (tocilizumab) Significantly Reduces Rheumatoid Arthritis Signs and Symptoms Regardless of Previous Therapy in Two New Global Studies
2. New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients
3. International ACTEMRA Rheumatoid Arthritis Study Highlighted in The Lancet
4. Roche Submits Application for FDA Approval of ACTEMRA(R) for the Treatment of Rheumatoid Arthritis
5. Two Pivotal Phase III Studies for Roches ACTEMRA(TM) (tocilizumab) Demonstrate Significant Improvement in Rheumatoid Arthritis Symptoms
6. Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD
7. Successful Results for Mymetics Corporations Mucosal HIV/AIDS Vaccine Viral Challenge Significantly Exceeds Expectations
8. Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel
9. Hibernation-On-Demand Drug Hydrogen Sulfide Significantly Improves Survival After Extreme Blood Loss
10. Phase III Data Show Vanda Pharmaceuticals Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia
11. New Study: Pine Bark Significantly Reduces Menstrual Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... 2013  Rhythm announced today the presentation of results ... of gastroparesis symptoms among diabetic patients in the U.S. ... among patients with both type 1 and type 2 ... with the more common type 2 disease. ... Associate Professor of Medicine at Harvard Medical School and ...
(Date:5/20/2013)... , May 20, 2013 With herbal ... resource available from the U.S. Pharmacopeial Convention (USP) will ... quality of the herbal ingredients used in these products. ... included in the new Herbal Medicines Compendium ... worldwide at hmc.usp.org . HMC ...
(Date:5/18/2013)... 18, 2013 The Open Paradigm Project, ... Occupy Psychiatry , and leading organizations in ... a social media campaign showcasing video testimonials by ... which focuses on pathology and illness rather than ... American Psychiatric Association,s (APA) rollout of its latest ...
Breaking Medicine Technology:Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S. 2Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S. 3Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S. 4New Compendium Offers Freely Available Testing Standards to Help Ensure the Quality of Herbal Ingredients Used in Traditional Medicines 2New Compendium Offers Freely Available Testing Standards to Help Ensure the Quality of Herbal Ingredients Used in Traditional Medicines 3New Social Media Campaign Features Stories Of Individuals Who Rejected Psychiatric Diagnoses 2New Social Media Campaign Features Stories Of Individuals Who Rejected Psychiatric Diagnoses 3
... U.S. Dept. of Defense Continues Study of Copper ... Infections and Improving Indoor Air Quality, NEW ... clinical trails determining the,antimicrobial effectiveness of copper, brass ... Association, announced CDA President Andrew G.,Kireta Sr. ...
... Serious Adverse Reactions, BERKELEY HEIGHTS, N.J., Nov. ... findings from the initial clinical,dosing of G4544, the ... treatment for diseases associated with accelerated bone loss. ... volunteers, has shown good,tolerance with oral bioavailability of ...
Cached Medicine Technology:Congressional Funds Awarded for Testing of Antimicrobial Copper Metals 2Congressional Funds Awarded for Testing of Antimicrobial Copper Metals 3Genta Completes Initial Clinical Dosing of G4544, a New Oral Drug for Bone Diseases 2Genta Completes Initial Clinical Dosing of G4544, a New Oral Drug for Bone Diseases 3Genta Completes Initial Clinical Dosing of G4544, a New Oral Drug for Bone Diseases 4Genta Completes Initial Clinical Dosing of G4544, a New Oral Drug for Bone Diseases 5
(Date:5/21/2013)... Limited mobility affects people in ways that ... more difficult to walk around, but everyday tasks like getting ... variety of medical products made to assist those who need ... toilet seat. , Raised toilet seats keep users ... up or sit down. They come in a variety of ...
(Date:5/20/2013)... traffic-related air pollution was significantly associated with higher ... research from the University of Cincinnati (UC) and ... is detailed in a study being published Tuesday, ... a peer-reviewed open access journal published by the ... within the National Institutes of Health (NIH). ...
(Date:5/20/2013)... May 21, 2013 The automated ... type into two categories - semi-automated and fully ... classified into five categories, namely, hospitals, pre-hospital, public ... forecast till 2017. Automated external defibrillators play an ... cardiac arrest victims. Considering the life-saving potential of ...
(Date:5/20/2013)... California (PRWEB) May 20, 2013 ... done, it's not always to become a celebrity. ... May 7, 2013 ABC News report (“Chris Christie ... made it clear that the surgery was not ... candidate or gain celebrity status as a former ...
(Date:5/20/2013)... Fastcare Miami Beach clinic advises ... its first symptoms, as if not treated, it may involve ... infection. Although a urinary tract infection in itself is not ... kidney infection called pyelonephritis. Women seem to have many more ... the same percentage as women after the age of fifty. ...
Breaking Medicine News(10 mins):Health News:JustHomeMedical.com Launches Raised Toilet Seats Category 2Health News:Early-life traffic-related air pollution exposure linked to hyperactivity 2Health News:North America Leads Automated External Defibrillator Market (AED), Says New Research Report at ReportsnReports.com 2Health News:North America Leads Automated External Defibrillator Market (AED), Says New Research Report at ReportsnReports.com 3Health News:The Lap Band Center: Dr. Atul Madan Applauds Chris Christie's Dedication to Family and Loss of 30 Pounds After Lap Band Surgery 2Health News:The Lap Band Center: Dr. Atul Madan Applauds Chris Christie's Dedication to Family and Loss of 30 Pounds After Lap Band Surgery 3Health News:Fastcare Advises on How to Prevent a UTI 2
... they face , ... Boston, Mass. (PRWEB) March 5, ... families enters difficult territory when it comes to administering anesthesia, finds ... Institute for Professionalism & Ethical Practice (IPEP). The study appears ...
... at the Sol Goldman Pancreatic Cancer Research Center at ... genome" sequencing on an individual with a hereditary form ... gene called PALB2 that is responsible for initiating the ... a genome scanning system to uncover suspect mutations in ...
... Provides Relief on Premiums, Re-enrollment OpportunitiesHARRISBURG, Pa., March 5 ... Pennsylvanians who were recently laid off from a job ... federal stimulus package may provide them with relief on ... their former employer for information."I want to let Pennsylvanians ...
... March 5 Enlighten Up!, a film for yoga ... IFC Center. The film takes a fresh look at yoga through ... filmmaker and yoga devotee Kate Churchill. , , Kate ... investigate yoga for six months, intrigued by the opportunity to delve ...
... March 5 The Barbara Ann Karmanos Cancer ... today announced that effective immediately Ann G. Schwartz, ... Executive Officer, and Paul Broughton has been appointed ... Schwartz is an excellent choice to lead us ...
... Win chair Anna Burger issued the ... which was attended by various Change to Win leaders. "There ... as complex and consequential as fixing our health care system. ... we can no longer turn a blind eye to solving ...
Cached Medicine News:Health News:Anesthesia for Children: Getting Informed Consent Under Duress 2Health News:Anesthesia for Children: Getting Informed Consent Under Duress 3Health News:Anesthesia for Children: Getting Informed Consent Under Duress 4Health News:'Personalized' genome sequencing reveals coding error in gene for inherited pancreatic cancer 2Health News:'Personalized' genome sequencing reveals coding error in gene for inherited pancreatic cancer 3Health News:Pennsylvanians Encouraged to Take Another Look at COBRA Options 2Health News:Enlighten Up! Peeks Behind the Curtain of Yoga, a Practice Powered by a Multi-Billion Dollar Industry 2Health News:Karmanos Cancer Institute Announces Interim Leadership 2Health News:Karmanos Cancer Institute Announces Interim Leadership 3Health News:Change to Win Statement on White House Health Care Forum 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: